Global Wound Debridement Market by Product (Ultrasonic Devices, Gels), by Method (Autolytic, Surgical) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

Global wound debridement market was valued at USD 3.97 Billion in 2020. It is projected to grow at a 6.1% compound annual growth rate (CAGR), between 2021 and 2028. Market growth is expected to be driven by the high prevalence of chronic conditions such as pressure ulcers and diabetic foot ulcers. Also, reimbursement options in developed countries and changes in lifestyles will help. The market is expected to be driven by the increasing number of accidents like road accidents, burns, or trauma events around the world. The market is expected to benefit from the increasing number of geriatrics and the increased awareness by governments and private organisations regarding wound care treatment.

Local manufacturers have had large-scale opportunities created by the COVID-19 epidemic. The restrictions on international movement have disrupted the supply chain of the major players. Local players were able to access the market and satisfy the unmet needs of end users. Due to the increasing number of patients, there is a shortage of medical supplies. To meet this demand, local players are expanding their production. Key companies have developed a variety of strategies and plans to increase their market share. These companies can partner with third-party vendors to increase their market share.

Market growth is also being driven by the growing adoption of debridement tools and methods to heal wounds faster. Infection can result from the inability to heal the wound due to the presence of microorganisms or toxins. Debridement is used to remove infected or dead tissues from the wound. This promotes healing.

Market growth is expected to be further boosted by the rising incidence of ulcers. According to the American Diabetes Association statistics, approximately 2.0% of Americans were affected by diabetic ulcers in 2014. In the U.S., approximately 600,000 people are also affected each year by venous ulcers. Awareness programs are needed for wound care treatment. The market is also driven by the development of healthcare infrastructure and advanced wound care products.

Product Insights

The largest share, 22.83%, was held by pads and medical gauze. The medical gauzes keep the wound moist, which aids in rapid healing. These wound care products are recommended for chronic wounds such as burn injuries, diabetic ulcers and pressure ulcers. Majority of the substances in gauzes are collagen, alginates, hydrogels and hydrocolloids.

Due to the increasing demand for gels and their wide variety of applications in treating various wounds, they accounted for the second largest share of the market in 2020. The segment of ultrasonic devices is expected to grow at the highest rate during the forecast period. Because ultrasonic devices can kill microorganisms directly at the wound site, without damaging the blood vessels, this is a significant advantage. The market can be divided into three types of products: gels, creams, ointments, medical gauzes and surgical devices.

Gels are able to maintain a moist environment for wounds and offer certain advantages over other products. Amorphous, clear gels are used to treat chronic wounds with sloughy or necrotic tissue. The main factors driving segment growth are the increasing incidence of chronic wounds and surgical site infections (SSI) in patients, as well as an increase in surgical wounds.

Method Insights

With a 27.12% share, the surgical wound debridement segment led the market in 2020. This is the most efficient way to debride a wound and create a clean bed. It also contributes to segment growth. The segment of autolytic wound debridement is expected to grow at a 6.7% CAGR over the forecast period. The market can be divided into three types of procedure: autolytic, enzymatic or surgical, and other.

Autolytic debridement refers to the removal of necrotic tissue and other damaged tissues from a wound site using the body's endogenous enzymes. These enzymes engulf certain components of cells/tissues. Although this method is more comfortable and efficient than other debridement methods, it can take longer. If significant autolysis does not occur within 1-2 weeks, another method of debridement may be considered.

Wound Type Insights

Due to an increasing number of diabetic foot conditions, the segment of diabetic foot problems dominated the market with a 32.89% share in 2020. Due to an increase in patients with various diseases that require prolonged hospital stays, the pressure ulcers market is expected to grow at the highest CAGR over the forecast period. The market can be divided into pressure ulcers and diabetic foot ulcers.

Uncontrolled diabetes mellitus is the main cause of diabetic foot ulcers. They are one of the most common chronic wounds. Diabetic foot ulcers are usually not painful and do not require prolonged hospitalization. This is due to the increasing number of diabetic foot ulcers around the world.

End-use Insights

With a 55.56% share, the hospitals segment dominated 2020's market. Homecare is forecast to grow at a 6.9% CAGR over the forecast period. The market can be divided into homecare, hospitals, and other end-uses.

Hospitals are being driven by the rising incidence of chronic wounds such as diabetic foot ulcers or venous leg ulcers. The incidence of chronic wounds will increase as people age, which could lead to a financial burden for society. The healthcare system spends more than USD 25 million annually in the United States on wound-related problems. According to the American Diabetes Association (ADA), there are more than 9-12 million Americans with chronic ulcers. The key factors driving segment growth are the rising incidence of diabetes and geriatric populations around the world.

Mode of Purchase Insights

With a 58.57% share, the prescription segment dominated 2020's market. OTC is expected to be the fastest-growing segment during the forecast period due to its lower price and increased approvals by regulatory authorities for OTC medication. The market can be divided by mode of purchase into prescription, over-the-counter, and other.

Market growth is being driven by the increasing number of chronic wounds, diabetic feet ulcers and necrotic wounds. The segment is also seeing an increase in generic alternatives being launched. Collagenase topical is the generic name for Santyl and it is the only prescription-based, topical debriding agent. These generic equivalents are becoming more popular, particularly since they have been proven as effective as the originals. It is also less expensive than original drugs and therefore more affordable for patients.

Regional Insights

North America held a 38.40% share in the market in 2020. The increasing number of surgeries, an increase in diabetes cases, and the presence key players in this market can explain why. Asia Pacific will see the greatest growth between 2021 and 2028 due to a variety of factors, including the growing geriatric population, improved healthcare infrastructure, and the large patient base.

A progressive economy, infrastructure reforms, high unmet need of large populations, and availability of skilled labor are all expected to drive the APAC market's growth. The introduction of Goods and Services Tax in India (GST), for instance, is expected to lower the tax burden and reduce its cascading effects. It is also expected to increase the ease of doing business here.

Market Share Insights & Key Companies

To increase market share, key players are involved in strategic initiatives such as mergers and acquisitions, regional expansions, expansion of the service portfolio, and collaborations. Many hospitals have outsourced their wound care to market participants in order to make the process run smoothly. Healogics, for example, offers outpatient wound care to hospitals. This facility is designed to heal complex wounds. It helps in revenue generation and cost savings. It offers inpatient consultations at over 60 partner hospitals. In January 2021, Healogics 2021 was launched by the company. This Healing program is designed to provide patients and healthcare professionals with the resources they need to improve their health, heal injuries, and avoid unnecessary amputations. These developments have a positive impact on the market growth. The following are some of the major players in the global market for wound debridement:

• Acelity L.P. Inc.

• Smith & Nephew

• B. Braun Melsungen AG

• Coloplast A/S

• ConvaTec Group

• Paul Hartmann

• Molnlycke Health Care

• Lohmann & Rauscher

• Medline Industries

• Integra Lifesciences

Up Market Research published a new report titled “Wound Debridement Market research report which is segmented by Product (Ultrasonic Devices, Gels), by Method (Autolytic, Surgical), By Players/Companies  Integra Lifesciences,  Paul Hartmann,  Medline Industries,  Lohmann & Rauscher,  B Braun Melsungen AG,  Smith & Nephew,  Coloplast A/S, Acelity LP Inc,  ConvaTec Group,  M¶lnlycke Health Care”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Wound Debridement Market Report Segments:

The market is segmented by Product (Ultrasonic Devices, Gels), by Method (Autolytic, Surgical).

Wound Debridement Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Wound Debridement Market

Overview of the regional outlook of the Wound Debridement Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Wound Debridement Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Wound Debridement Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Ultrasonic Devices

                2. Gels

                1. Autolytic

                2. Surgical

8. Market scenario by region, sub-region, and country.
9. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
10. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
11. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Wound Debridement Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Wound Debridement Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.